Clinical Trials Logo

Filter by:
NCT ID: NCT06435975 Completed - Rectal Cancer Clinical Trials

Physical Activity in Rectal Cancer Survivors

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a telehealth-based personalized physical activity intervention in adult patients diagnosed with Stage I-III rectal cancer. The main question it aims to answer are how to better understand the experiences of rectal cancer survivors who are coping with bowel dysfunction and how physical activity can improve their quality of life. Participants will be asked to: 1. Complete surveys to assess bowel function and quality of life 2. Participate in 12 Telehealth Sessions (one session a week) to discuss and review bowel dysfunction 3. Perform daily physical activity

NCT ID: NCT06435338 Completed - Hpv Clinical Trials

Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old

HPV Decide
Start date: December 13, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to learn if a patient decision tool for HPV vaccination works for decision-making among adults ages 27-45. Researchers will compare a web-based patient decision tool to an information sheet to see if the tool works for decision-making. Participants will take a baseline survey, view the intervention or control condition, and then take a follow-up survey.

NCT ID: NCT06434181 Completed - Healthy Clinical Trials

Beetroot Juice for Boosting Immunity During a Time of Stress.

Start date: April 11, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the present study is to explore the effects of a dietary nitrate supplement (i.e., beetroot juice) on nitric oxide levels, immunity, mood, and cardiovascular activity during and following final exam stress in healthy individuals.

NCT ID: NCT06433466 Completed - Vaping Clinical Trials

Influencer Marketing: a Survey-based Experiment

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

Young adults (N = 1,500) will participate in the online survey-based experiment. They will be randomly shown 10 videos, featuring influencers promoting e-cigarettes alongside healthy lifestyle activities (experimental group), or a healthy lifestyle activity alone (control). After watching each video, participants will rate perceptions of influencer credibility (i.e., honesty, trustworthiness, knowledge, attractiveness, intelligence, and popularity) on the scale of 0 (e.g., dishonest) to 100 (honest). Among all participants, harm perceptions of e-cigarettes will be assessed. Susceptibility to use e-cigarettes will be assessed among never users. These outcomes will then be compared among participants who perceived influencers as credible and those who perceived influencers as non-credible.

NCT ID: NCT06432374 Completed - Anxiety Clinical Trials

Written Exposure Therapy for Nurses

Start date: February 1, 2022
Phase: Early Phase 1
Study type: Interventional

Nurses often experience elevated levels of stress, overwork, and trauma in the workplace, leading to posttraumatic stress disorder (PTSD), depression, burnout, and even nurse turnover. While effective therapies for PTSD exist, barriers to treatment arise from nursing culture, such as workplace stigma about mental health problems, fear that psychological status may impact performance evaluations, and demands of shiftwork. There is a pressing need for scalable evidence-based interventions tailored to nursing culture to effectively address PTSD and related mental health issues. The study aimed to assess the feasibility, safety, and acceptability of a tailored evidence-based treatment, Written Exposure Therapy (WET), for nurses experiencing work-related traumatic stress. This single-arm open pilot study with pre- and post-intervention assessments, included participants from two nursing schools' alumni. Eligibility criteria included nurses screening positive for work-related trauma with a report of at least two PTSD symptoms. Participants engaged in a self-administered, asynchronous, five-week online writing session, facilitated by WET-trained nurses. Outcomes measures (PTSD, depression, anxiety, burnout, and intention to quit) were assessed at baseline, post-intervention, and 5-weeks follow-up.

NCT ID: NCT06428890 Completed - Prehypertension Clinical Trials

Effect of 7 Days of Grape Seed Extract Supplementation on Cold Pressor Test and Muscle Metaboreflex in Individuals With Elevated and Stage 1 Hypertension

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study aimed to assess the effect of the supplementation with grape seed extract (GSE) on blood pressure during static handgrip exercise and muscle metaboreflex in individuals with elevated and state 1 hypertension.

NCT ID: NCT06424795 Completed - Clinical trials for Respiratory Syncytial Virus Infection

Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants

Start date: December 21, 2019
Phase:
Study type: Observational

The goal of this observational study is to learn about further wheezing in infants with RSV infection.. The main question it aims to answer is: If infant factors, the infant immune response in the nose and the bacteria that reside in the nose at the time of primary RSV infection can predict/classify infants with recurrent wheezing during the following year. A secondary aim is to identify infant immune response factors in the nose and patterns of bacteria in the nose during primary RSV infection that may help us understand why recurrent wheezing occurs. Researchers will compare infants with repeated episodes of wheezing to infants who do not have further wheezing. Participants will be full term infants with their first RSV infection. We will collect information on the pregnancy and birth history as well as the signs and symptoms of RSV infection. Two nasal swabs and a nasal wash will be collected from the infants. Six weeks following the RSV infection we will begin contact with the families biweekly to determine if the infant has recurrent wheezing confirmed by a medical provider. Follow-up will continue for approximately 1 year, through a second winter season.

NCT ID: NCT06423625 Completed - Clinical trials for Acute Myocardial Infarction

Hemorrhagic MI Prediction Score Model

MIRON-PREDICT
Start date: June 1, 2023
Phase:
Study type: Observational

Developing a prediction score model for predicting the likelihood of Hemorrhagic MI

NCT ID: NCT06422104 Completed - Clinical trials for Isolated Focal Hand Dystonia

Neuromodulation Therapy for Task-Specific Dystonia

Start date: August 23, 2018
Phase: N/A
Study type: Interventional

This study aims to apply a non-invasive brain stimulation technology called repetitive Transcranial Magnetic Stimulation (rTMS) in patients with focal hand dystonia (FHD). The goal of the study is to identify which cortical target (premotor cortex (PMC) or primary somatosensory cortex (PSC)) will show benefit after active rTMS compared to sham rTMS. A secondary goal of the study is to understand if 10 Hz rTMS can show behavioral benefit compared to sham rTMS. The study will evaluate rTMS response using measures if writing on a sensor tablet, examiner and patient dystonia rating scales and brain imaging scan (functional MRI) to understand brain changes after rTMS. Safety measures include adherence to TMS guidelines and thorough medical screening to prevent seizures.

NCT ID: NCT06421714 Completed - Healthy Volunteers Clinical Trials

A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants

Start date: August 16, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess in healthy adult male participants the effects of itraconazole on the pharmacokinetics of venglustat and to assess the safety and tolerability of venglustat with and without coadministration of itraconazole. The maximum duration for participants from screening is between 32 to 62 days.